Advisor Group’s CASI Pharmaceuticals CASI Stock Holding History

Advisor Group’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Buy	+1	New	+$32	﹤0.01%	5313
2019 Q1	–	Sell	-9	Closed	–	–	5218
2018 Q4	$0	Hold	9	–	–	﹤0.01%	5109
2018 Q3	$0	Hold	9	–	–	﹤0.01%	5108
2018 Q2	$1K	Hold	9	–	–	﹤0.01%	4777
2018 Q1	$0	Hold	9	–	–	﹤0.01%	4954
2017 Q4	$0	Hold	9	–	–	﹤0.01%	4962
2017 Q3	$0	Hold	9	–	–	﹤0.01%	4842
2017 Q2	$0	Sell	9 -4	-31%	-$43	﹤0.01%	4791
2017 Q1	$0	Hold	13	–	–	﹤0.01%	4689
2016 Q4	$0	Hold	13	–	–	﹤0.01%	4508
2016 Q3	$0	Hold	13	–	–	﹤0.01%	4477
2016 Q2	$0	Buy	+13	New	+$164	﹤0.01%	4401

Other funds holding CASI

IACGFIA

IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Advisor Group's CASI Position: Q4 2019 in Review

Advisor Group opened a new position in CASI Pharmaceuticals (CASI) in Q4 2019: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #5313 among its holdings. This is a return to the name: Advisor Group previously reported a position in CASI as recently as Q4 2018.

Advisor Group first reported a position in CASI in Q2 2016 and has held it in 12 quarters since. The position peaked at $1K in Q2 2018. 53 funds tracked by Wall St. Rank hold CASI as of Q4 2019.

Advisor Group held 1 share of CASI Pharmaceuticals worth $0 as of Q4 2019.
CASI Pharmaceuticals was a new Advisor Group position in Q4 2019.
CASI Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5313 holding.
Advisor Group first reported a position in CASI Pharmaceuticals in Q2 2016 and has held it in 12 quarters since.
Advisor Group's CASI Pharmaceuticals position peaked at $1K in Q2 2018.
53 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.